by Lyla El-Fayomi | Feb 24, 2025
I’m back with a post-holiday double edition of RMNU🔬! I cover stem cell patches for failing hearts, a novel skeletal tissue that’s been (re-)discovered, an update on BlueRock’s Parkinson’s therapy, and more. Bookmark, or dive right in! Pick of the Month(s) Stem cell...
by Lyla El-Fayomi | Nov 19, 2024
Millions of placentas are discarded annually around the world. Given the regenerative medical potential demonstrated by placenta-derived tissue over the years, this is quite an unfortunate statistic. First used in 1910, placenta-derived tissue was abandoned in the...
by Lyla El-Fayomi | Nov 14, 2024
I’ve once again divided up the October edition of RMNU🔬 by trending research topic. Read on for remarkable placental science, new research involving in vivo genetic engineering, and more! Trend of the month: Healing via placenta Millions of placentas are discarded...
by Lyla El-Fayomi | Sep 12, 2024
Welcome to a special edition of my blog that summarizes all the big news from the summer. I hope you’ve all been able to soak up (safely) as much sun as possible. Below, I cover the latest in aging, global trends in clinical trials for engineered biomaterials,...
by Don Gibbons | May 28, 2024
Spinal cord injury (SCI) seemed like a logical first target for pluripotent stem cell therapy. In many cases a discrete lesion blocks the brain’s nerve signals from reaching the muscles or other tissues they are supposed to instruct. The solution: turn stem cells into...
by Medicine by Design | May 6, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits...
Comments